• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GLAUKOS CORPORATION ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM; AQUEOUS SHUNT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GLAUKOS CORPORATION ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM; AQUEOUS SHUNT Back to Search Results
Model Number IS3-US
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/01/2023
Event Type  malfunction  
Event Description
It was reported that following an uneventful right eye (od) cataract plus trabecular microbypass stent system procedure, the patient presented on postoperative day one (1) with a dislodged stent in the inferior angle.Per report, the patient has three (3) stents placed.Through follow-up, the surgeon conferred with expert opinion md, who reported discussing postoperative management of hyphema, medication, and optimal technical approach.
 
Manufacturer Narrative
Additional information: the device was not available; therefore, product testing on the actual device could not be performed.The device identifiers were not provided; therefore, the device history records for this device lot number could not be reviewed.A review of the device labeling was completed.Dislodged/dislocated stent is identified in the labeling as a known inherent risk of trabecular micro-bypass stent procedure.The ifu adequately provides instructions for stent implantation, precautions, and warnings for the proper use and handling of the device.An adverse event appears to have occurred, but does not appear to have been a problem with the device or the way it was used.Dislodged/dislocated stent is an established risk associated with use of the device, which is clearly specified in the product''s labeling.Based on the information received, the root cause of the reported event could not be conclusively identified.Mfr# reference: (b)(4).
 
Manufacturer Narrative
Mfr# reference: (b)(4).
 
Event Description
Through follow-up, the following additional information was received.The surgeon reiterated an uneventful right eye (od) cataract surgery followed by stent implantation.Per report, there was no adverse patient impact, no intervention required, and the patient is being monitored.The most recent patient status was described as "doing well" with the stent remaining in the angle.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM
Type of Device
AQUEOUS SHUNT
Manufacturer (Section D)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer (Section G)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer Contact
brittany massey
229 avenida fabricante
san clemente, CA 92672
949367960
MDR Report Key17390050
MDR Text Key319862504
Report Number2032546-2023-00077
Device Sequence Number1
Product Code KYF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220032
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/25/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberIS3-US
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-